Batenburg J J, den Breejen J N, Yost R W, Haagsman H P, van Golde L M
Biochim Biophys Acta. 1986 Oct 3;878(3):301-9. doi: 10.1016/0005-2760(86)90237-7.
Glycerol 3-phosphate acylation was studied in type II cells isolated from adult rat lung. The process was found to be largely microsomal. In the microsomes phosphatidic acid is the main product of glycerol 3-phosphate acylation. Glycerol-3-phosphate acyltransferase is rate limiting in the phosphatidic acid formation by the microsomes. Type II cell microsomes incorporate palmitoyl and oleoyl residues into phosphatidic acid at an equal rate if palmitoyl-CoA and oleoyl-CoA are added separately. However, if palmitoyl-CoA and oleoyl-CoA are added as an equimolar mixture the unsaturated fatty acyl moiety is incorporated much faster. Under the latter conditions monoenoic species constitute the most abundant products of glycerol 3-phosphate acylation. The microsomes incorporate both palmitoyl and oleoyl residues readily into both the 1- and 2-position of phosphatidic acid, even when palmitoyl-CoA and oleoyl-CoA are added together. Assuming that both phosphatidic acid phosphatase and cholinephosphotransferase do not discriminate against substrates with an unsaturated acyl moiety at the 1-position and a saturated acyl moiety at the 2-position, the last two observations indicate that a considerable percentage of phosphatidylcholine molecules synthesized de novo may have a saturated fatty acid at the 2-position and an unsaturated fatty acid at the 1-position, and that remodeling at the 1-position may be important for the formation of surfactant dipalmitoylphosphatidylcholine. They also indicate that type II cell microsomes are capable of synthesizing the dipalmitoyl species of phosphatidic acid. However, since there is a preference for the acylation of glycerol 3-phosphate with unsaturated fatty acyl residues, the percentage of dipalmitoyl species in the synthesized phosphatidic acid, and thereby the percentage of dipalmitoyl species in the phosphatidylcholine synthesized de novo, will probably depend on the relative availability of the various acyl-CoA species.
对从成年大鼠肺中分离出的II型细胞中的3 - 磷酸甘油酰化作用进行了研究。发现该过程主要发生在微粒体中。在微粒体中,磷脂酸是3 - 磷酸甘油酰化的主要产物。3 - 磷酸甘油酰基转移酶是微粒体形成磷脂酸的限速酶。如果分别添加棕榈酰辅酶A和油酰辅酶A,II型细胞微粒体以相同的速率将棕榈酰基和油酰基残基掺入磷脂酸中。然而,如果将棕榈酰辅酶A和油酰辅酶A作为等摩尔混合物添加,则不饱和脂肪酰基部分的掺入速度要快得多。在后一种条件下,单烯类物质是3 - 磷酸甘油酰化的最丰富产物。即使将棕榈酰辅酶A和油酰辅酶A一起添加,微粒体也能将棕榈酰基和油酰基残基轻松地掺入磷脂酸的1位和2位。假设磷脂酸磷酸酶和胆碱磷酸转移酶对1位具有不饱和酰基部分和2位具有饱和酰基部分的底物没有歧视,最后这两个观察结果表明,相当比例的从头合成的磷脂酰胆碱分子可能在2位具有饱和脂肪酸,在1位具有不饱和脂肪酸,并且1位的重塑对于表面活性剂二棕榈酰磷脂酰胆碱的形成可能很重要。它们还表明II型细胞微粒体能够合成磷脂酸中的二棕榈酰类物质。然而,由于更倾向于用不饱和脂肪酰基残基对3 - 磷酸甘油进行酰化,合成的磷脂酸中二棕榈酰类物质的百分比,进而从头合成的磷脂酰胆碱中二棕榈酰类物质的百分比,可能取决于各种酰基辅酶A物种的相对可用性。